Ignite Creation Date:
2025-12-24 @ 7:09 PM
Ignite Modification Date:
2025-12-30 @ 9:12 AM
Study NCT ID:
NCT04001803
Status:
COMPLETED
Last Update Posted:
2023-04-14
First Post:
2019-06-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US)
Sponsor:
ViiV Healthcare
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-08
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-18
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-10
First Submit QC Date:
None
Study First Post Date:
2019-06-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-09-29
Results First Submit QC Date:
None
Results First Post Date:
2022-01-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-16
Last Update Post Date:
2023-04-14
Last Update Post Date Type:
ACTUAL